Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share.

Full Year and Q4 Group performance highlights Sales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in Q4, comparable sales growth 1%, despite double-digit ...

"Net sales increased during the fourth quarter by 41.5 percent to SEK 64.2 million, compared with the corresponding quarter of 2023. The growth and strong performance are a result of robust developmen ...

Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical ...

Apple's ecosystem, premium positioning, and focus on privacy are driving its dominance in health tech, poised to disrupt ...

As part of ongoing efforts to reinforce Seychelles' presence in the Turkish market, Tourism Seychelles engaged in a series of ...

Kolkata locals mourn the decline of the iconic yellow Ambassador taxis, once a symbol of the city’s identity. With emissions ...

In terms of liquidity and interest, the mean open interest for Medtronic options trades today is 942.55 with a total volume of 26,313.00.

WORK Medical Technology Group LTD ("WORK Medical" or the "Company") , a supplier of medical devices in China, today reported its financial results for the fiscal year ended September 30, 2024. Mr.

Valentine's Day has long been celebrated as a day of romance filled with red roses, heart-shaped candies and chocolate boxes.

The Greater Middle East is home to a rich genetic diversity that remains largely untapped in genomic research. This Perspective explores its potential for rare disease research, obstacles limiting ...

Healthcare REITs are delivering healthy dividends while capitalizing on the growing demand for medical facilities. In this ...